Gam Holding Ag Regenxbio Inc. Transaction History

Gam Holding Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $504,187 - $791,725	-17,332 Reduced 40.1%	25,894 $1.09 Million
Q1 2021 May 10, 2021	BUY	$33.61 - $49.95 $1.45 Million - $2.16 Million	43,226 New	43,226 $1.47 Million
Q4 2020 Feb 10, 2021	SELL	$26.52 - $49.35 $3.59 Million - $6.69 Million	-135,475 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$27.01 - $40.26 $815,702 - $1.22 Million	30,200 Added 28.69%	135,475 $3.73 Million
Q1 2020 May 12, 2020	SELL	$21.5 - $54.2 $135,450 - $341,460	-6,300 Reduced 5.65%	105,275 $3.41 Million
Q1 2019 May 10, 2019	BUY	$40.82 - $62.45 $1.95 Million - $2.98 Million	47,675 Added 74.61%	111,575 $6.39 Million
Q4 2018 Feb 08, 2019	SELL	$39.11 - $75.15 $301,147 - $578,655	-7,700 Reduced 10.75%	63,900 $2.68 Million
Q1 2018 May 15, 2018	BUY	$24.05 - $37.5 $875,420 - $1.37 Million	36,400 Added 103.41%	71,600 $2.14 Million
Q4 2017 Feb 14, 2018	BUY	$26.0 - $34.6 $470,600 - $626,260	18,100 Added 105.85%	35,200 $1.17 Million
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $307,800 - $563,445	17,100	17,100 $563,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.